Mirum Pharmaceuticals, Inc. Common Stock (MIRM) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for MIRM. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Frazier Life Sciences Management, | 7,679,684 | $899M | UNCHANGED |
| Jupiter Topco | 5,909,184 | $692M | NEW |
| Vanguard | 5,041,815 | $590M | INCREASED |
| BlackRock | 4,390,063 | $514M | INCREASED |
| FMR | 3,670,314 | $430M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Eric Bjerkholt (CHIEF FINANCIAL OFFICER) | EXERCISE | 18,333 | 2026-09-11 | |
| Eric Bjerkholt (CHIEF FINANCIAL OFFICER) | SELL | 9,943 | $978K | 2026-09-11 |
| Jolanda Howe (SVP, GLOBAL CONTROLLER) | SELL | 658 | $66K | 2026-09-02 |
| Christopher Peetz (CHIEF EXECUTIVE OFFICER) | EXERCISE | 30,000 | $88K | 2026-09-01 |
| Christopher Peetz (CHIEF EXECUTIVE OFFICER) | SELL | 21,688 | $2M | 2026-09-01 |
Full institutional holdings, insider history, and congressional trades for Mirum Pharmaceuticals, Inc. Common Stock on SentiSense.